申请人:Aron S.A.
公开号:US04246272A1
公开(公告)日:1981-01-20
The invention relates to a compound selected from the group consisting of compounds of the formula: ##STR1## in which R.sub.1, R.sub.2 and R.sub.3 are independently selected from hydrogen, halogen, trifluoromethyl, nitro, C.sub.1-4 alkoxy and C.sub.1-4 alkyl, R.sub.4 represents a heterocyclic radical selected from the radicals having the formulae ##STR2## in which R.sub.5 and R.sub.6 are independently selected from hydrogen, C.sub.1-4 alkyl, phenyl and halophenyl, R.sub.7 is selected from hydrogen and C.sub.1-4 alkyl, and a pharmaceutically acceptable acid addition salt thereof. These compounds are useful for the treatment of gastric ulcers.
本发明涉及选择自公式组成的化合物:##STR1##
其中R.sub.1,R.sub.2和R.sub.3独立选择自氢,卤素,三氟甲基,硝基,C.sub.1-4烷氧基和C.sub.1-4烷基,R.sub.4代表从具有以下式的基团中选择的杂环基团:##STR2##
其中R.sub.5和R.sub.6独立选择自氢,C.sub.1-4烷基,苯基和卤代苯基,R.sub.7选择自氢和C.sub.1-4烷基,并且其药学可接受的酸加合物。这些化合物对于治疗胃溃疡有用。